BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.63% | -5.04% | -10.21% | -17.94% | -35.55% |
| Total Depreciation and Amortization | -11.66% | 38.53% | -14.73% | -50.84% | -52.40% |
| Total Amortization of Deferred Charges | -51.62% | -42.74% | -29.55% | 21.88% | 71.21% |
| Total Other Non-Cash Items | -19.40% | 74.24% | 222.69% | 223.54% | 262.26% |
| Change in Net Operating Assets | -133.80% | -33.28% | -14.88% | 4.68% | 113.22% |
| Cash from Operations | -109.63% | -22.76% | -3.26% | 19.45% | 40.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.43% | 4.76% | 31.57% | 24.61% | 16.49% |
| Total Debt Repaid | -5,275.40% | -0.94% | -1,206.67% | 46.15% | 65.29% |
| Issuance of Common Stock | -- | 4,672.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 109.95% | 61.85% | 28.42% | -19.12% | -39.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.00% | 283.94% | 154.74% | 24.95% | 770.59% |